Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices
- PMID: 37974477
- DOI: 10.1002/jmri.29114
Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices
Abstract
Thyroid eye disease (TED) is a complex autoimmune disorder that impairs various orbital structures, leading to cosmetic damage and vision loss. Magnetic resonance imaging (MRI) is a fundamental diagnostic tool utilized in clinical settings of TED, for its accurate demonstration of orbital lesions and indication of disease conditions. The application of quantitative MRI has brought a new prospect to the management and research of TED, offering more detailed information on morphological and functional changes in the orbit. Therefore, many researchers concentrated on the implementation of different quantitative MRI techniques on TED for the exploration of clinical practices. Despite the abundance of studies utilizing quantitative MRI in TED, there remain considerable barriers and disputes on the best exploitation of this tool. This could possibly be attributed to the complexity of TED and the fast development of MRI techniques. It is necessary that clinical and radiological aspects of quantitative MRI in TED be better integrated into comprehensive insights. Hence, this review traces back 30 years of publications regarding quantitative MRI utilized in TED and elucidates this promising application in the facets of imaging techniques and clinical practices. We believe that a deeper understanding of the application of quantitative MRI in TED will enhance the efficacy of the multidisciplinary management of TED. LEVEL OF EVIDENCE: 2 TECHNICAL EFFICACY: Stage 3.
Keywords: clinical practices; multisequence; quantitative MRI; thyroid eye disease.
© 2023 International Society for Magnetic Resonance in Medicine.
Similar articles
-
TOM500: A Multi-Organ Annotated Orbital MRI Dataset for Thyroid Eye Disease.Sci Data. 2025 Jan 13;12(1):60. doi: 10.1038/s41597-025-04427-9. Sci Data. 2025. PMID: 39805915 Free PMC article.
-
Immune-related visual dysfunction in thyroid eye disease: a combined orbital and brain neuroimaging study.Eur Radiol. 2024 Jul;34(7):4516-4526. doi: 10.1007/s00330-023-10309-8. Epub 2023 Dec 19. Eur Radiol. 2024. PMID: 38112763
-
Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI.Int Ophthalmol. 2024 May 3;44(1):213. doi: 10.1007/s10792-024-03138-1. Int Ophthalmol. 2024. PMID: 38700596
-
A systematic review of multimodal clinical biomarkers in the management of thyroid eye disease.Rev Endocr Metab Disord. 2022 Jun;23(3):541-567. doi: 10.1007/s11154-021-09702-9. Epub 2022 Jan 23. Rev Endocr Metab Disord. 2022. PMID: 35066781
-
Phenotypes of Thyroid Eye Disease.Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S28-S33. doi: 10.1097/IOP.0000000000001147. Ophthalmic Plast Reconstr Surg. 2018. PMID: 29905636 Review.
Cited by
-
Radiological Activity Score (RAS)-MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi-Ethnic Thyroid Eye Disease Population.Clin Endocrinol (Oxf). 2025 Sep;103(3):385-395. doi: 10.1111/cen.15272. Epub 2025 May 20. Clin Endocrinol (Oxf). 2025. PMID: 40391843 Free PMC article.
-
Research progress of optic nerve imaging during 1991-2023: a bibliometric analysis.Quant Imaging Med Surg. 2024 Sep 1;14(9):6566-6578. doi: 10.21037/qims-24-870. Epub 2024 Aug 28. Quant Imaging Med Surg. 2024. PMID: 39281143 Free PMC article.
-
A multimodal deep learning model for predicting severe hemorrhage in placenta previa.Sci Rep. 2023 Oct 13;13(1):17320. doi: 10.1038/s41598-023-44634-1. Sci Rep. 2023. PMID: 37833537 Free PMC article.
-
TOM500: A Multi-Organ Annotated Orbital MRI Dataset for Thyroid Eye Disease.Sci Data. 2025 Jan 13;12(1):60. doi: 10.1038/s41597-025-04427-9. Sci Data. 2025. PMID: 39805915 Free PMC article.
-
Advances in artificial intelligence in thyroid-associated ophthalmopathy.Front Endocrinol (Lausanne). 2024 Apr 23;15:1356055. doi: 10.3389/fendo.2024.1356055. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38715793 Free PMC article. Review.
References
-
- Bartalena L, Tanda ML. Graves' Ophthalmopathy. N Engl J med 2009;360:994‐1001.
-
- Lo C, Ugradar S, Rootman D. Management of graves myopathy: Orbital imaging in thyroid‐related orbitopathy. J AAPOS 2018;22:256.e1‐256.e9.
-
- Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: Impact of quality of care. Eur J Endocrinol 2011;164:649‐655.
-
- Bartalena L, Tanda ML. Current concepts regarding Graves' orbitopathy. J Intern med 2022;292:692‐716.
-
- Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. Eur J Endocrinol 2021;185:G43‐G67.
Publication types
MeSH terms
Grants and funding
- JYLJ202202/Clinical Acceleration Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
- 20DZ22708/Science and Technology Commission of Shanghai Municipality
- 2022ZZ01003/Shanghai Eye Disease Research Center
- 81930024/National Natural Science Foundation of China
- 82071003/National Natural Science Foundation of China
- 82000879/National Natural Science Foundation of China
- 82271072/National Natural Science Foundation of China
- 82271122/National Natural Science Foundation of China
- Shanghai Key Clinical Specialty
- SHDC2020CR3051B/Clinical Research Plan of SHDC
- JYJC202115/Cross disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
LinkOut - more resources
Full Text Sources
Medical
Research Materials